• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环氧化酶-2抑制胆管癌细胞中Fas介导的细胞凋亡。

COX-2 inhibits Fas-mediated apoptosis in cholangiocarcinoma cells.

作者信息

Nzeako Ugochukwu C, Guicciardi Maria Eugenia, Yoon Jung-Hwan, Bronk Steven F, Gores Gregory J

机构信息

Division of Gastroenterology and Hepatology, Mayo Medical School, Clinic, and Foundation, 200 First Street SW, Rochester, MN 55905, USA.

出版信息

Hepatology. 2002 Mar;35(3):552-9. doi: 10.1053/jhep.2002.31774.

DOI:10.1053/jhep.2002.31774
PMID:11870367
Abstract

Fas expression has been shown to negatively regulate the progression of cholangiocarcinoma cells in xenografts. However, many human cholangiocarcinomas express Fas, suggesting these cancers have developed mechanisms to inhibit Fas-mediated apoptosis. Cyclooxygenase-2 (COX-2), which generates prostanoids, is expressed by many cholangiocarcinomas. Therefore, our aim was to determine whether COX-2 expression inhibits death receptor--mediated apoptosis in KMBC cells, a cholangiocarcinoma cell line. These cells express messenger RNA for the death receptors Fas, tumor necrosis factor receptor 1 (TNF-R1), death receptor 4 (DR4), and DR5. Agonists for these death receptors, CH-11, TNF-alpha, and TRAIL all induced apoptosis. However, COX-2, whether induced by proinflammatory cytokines or transient transfection, only significantly inhibited Fas-mediated apoptosis. The COX-2 inhibitor NS-398 restored Fas-mediated apoptosis in COX-2 transfected cells. Prostaglandin E2 reduced apoptosis and mitochondrial depolarization after treatment with the Fas agonist CH-11. Of a variety of antiapoptotic proteins examined, COX-2/prostaglandin E2 only increased expression of Mcl-1, an antiapoptotic member of the Bcl-2 family. In conclusion, these data suggest that prostanoid generation by COX-2 specifically inhibits Fas-mediated apoptosis, likely by up-regulating Mcl-1 expression. Pharmacologic inhibition of COX-2 may be useful in augmenting Fas-mediated apoptosis of cholangiocarcinoma cells.

摘要

Fas表达已被证明对异种移植中胆管癌细胞的进展具有负调控作用。然而,许多人类胆管癌表达Fas,这表明这些癌症已形成抑制Fas介导的细胞凋亡的机制。生成前列腺素的环氧合酶-2(COX-2)在许多胆管癌中表达。因此,我们的目的是确定COX-2表达是否抑制胆管癌细胞系KMBC细胞中死亡受体介导的细胞凋亡。这些细胞表达死亡受体Fas、肿瘤坏死因子受体1(TNF-R1)、死亡受体4(DR4)和DR5的信使RNA。这些死亡受体的激动剂CH-11、TNF-α和TRAIL均诱导细胞凋亡。然而,COX-2无论是由促炎细胞因子诱导还是通过瞬时转染,都仅显著抑制Fas介导的细胞凋亡。COX-2抑制剂NS-398可恢复COX-2转染细胞中Fas介导的细胞凋亡。用Fas激动剂CH-11处理后,前列腺素E2可减少细胞凋亡和线粒体去极化。在检测的多种抗凋亡蛋白中,COX-2/前列腺素E2仅增加了Bcl-2家族抗凋亡成员Mcl-1的表达。总之,这些数据表明COX-2生成前列腺素可能通过上调Mcl-1表达特异性抑制Fas介导的细胞凋亡。COX-2的药理抑制可能有助于增强胆管癌细胞中Fas介导的细胞凋亡。

相似文献

1
COX-2 inhibits Fas-mediated apoptosis in cholangiocarcinoma cells.环氧化酶-2抑制胆管癌细胞中Fas介导的细胞凋亡。
Hepatology. 2002 Mar;35(3):552-9. doi: 10.1053/jhep.2002.31774.
2
Cholangiocarcinomas express Fas ligand and disable the Fas receptor.胆管癌表达Fas配体并使Fas受体失活。
Hepatology. 1999 Dec;30(6):1398-404. doi: 10.1002/hep.510300618.
3
Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition.环氧化酶-2(COX-2)抑制剂可使肿瘤细胞特异性地对死亡受体诱导的凋亡敏感,且与COX-2抑制作用无关。
Oncogene. 2003 Sep 11;22(39):8021-30. doi: 10.1038/sj.onc.1206837.
4
Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma.环氧化酶-2抑制通过死亡受体和线粒体诱导肝癌细胞凋亡信号传导。
Cancer Res. 2006 Jul 15;66(14):7059-66. doi: 10.1158/0008-5472.CAN-06-0325.
5
Cyclooxygenase-2 overexpression inhibits death receptor 5 expression and confers resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human colon cancer cells.环氧化酶-2的过表达抑制死亡受体5的表达,并使人结肠癌细胞对肿瘤坏死因子相关凋亡诱导配体诱导的凋亡产生抗性。
Cancer Res. 2002 Sep 1;62(17):4903-8.
6
Susceptibility of cholangiocarcinoma cells to parthenolide-induced apoptosis.胆管癌细胞对小白菊内酯诱导凋亡的敏感性。
Cancer Res. 2005 Jul 15;65(14):6312-20. doi: 10.1158/0008-5472.CAN-04-4193.
7
Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.环氧化酶-2过表达通过抑制人结肠癌细胞中细胞色素c依赖性凋亡途径降低凋亡易感性。
Cancer Res. 2002 Nov 1;62(21):6323-8.
8
Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells.死亡受体调节与塞来昔布诱导人肺癌细胞凋亡
J Natl Cancer Inst. 2004 Dec 1;96(23):1769-80. doi: 10.1093/jnci/djh322.
9
Accelerative effect of a selective cyclooxygenase-2 inhibitor on Fas-mediated apoptosis in human neutrophils.选择性环氧化酶-2抑制剂对人中性粒细胞中Fas介导的细胞凋亡的促进作用。
Int Immunopharmacol. 2006 Mar;6(3):334-41. doi: 10.1016/j.intimp.2005.08.017. Epub 2005 Sep 2.
10
COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis.环氧化酶-2抑制剂使人类肝癌细胞对肿瘤坏死因子相关凋亡诱导配体(TRAIL)诱导的凋亡敏感。
Int J Mol Med. 2006 Jul;18(1):41-7.

引用本文的文献

1
Repurposing of Indomethacin and Naproxen as anticancer agents: progress from 2017 to present.消炎痛和萘普生作为抗癌药物的重新利用:2017年至今的进展
RSC Adv. 2024 Dec 23;14(54):40031-40057. doi: 10.1039/d4ra07581a. eCollection 2024 Dec 17.
2
Expression of and as potential biomarkers in chronic myeloid leukemia patients in Brazil.巴西慢性髓性白血病患者中 和 作为潜在生物标志物的表达情况。
Front Oncol. 2024 Oct 10;14:1443346. doi: 10.3389/fonc.2024.1443346. eCollection 2024.
3
derived exopolysaccharide enhances cell cycle arrest, apoptosis, necrosis, autophagy and COX-2 down regulation in liver cancer cells.
衍生胞外多糖可增强肝癌细胞的细胞周期阻滞、凋亡、坏死、自噬以及环氧合酶-2(COX-2)的下调。
Biotechnol Rep (Amst). 2024 Jun 20;43:e00848. doi: 10.1016/j.btre.2024.e00848. eCollection 2024 Sep.
4
Recent Advancements in Refashioning of NSAIDs and their Derivatives as Anticancer Candidates.新型 NSAIDs 及其衍生物的重塑及其作为抗癌候选药物的最新进展。
Curr Pharm Des. 2024;30(16):1217-1239. doi: 10.2174/0113816128304230240327044201.
5
Selective COX-2 inhibitors do not increase gastrointestinal reactions after colorectal cancer surgery: a systematic review and meta-analysis.选择性 COX-2 抑制剂不会增加结直肠癌手术后的胃肠道反应:系统评价和荟萃分析。
BMC Gastroenterol. 2023 Aug 14;23(1):281. doi: 10.1186/s12876-023-02918-w.
6
Role of TRP Channels in Liver-Related Diseases.TRP 通道在肝脏相关疾病中的作用。
Int J Mol Sci. 2023 Aug 7;24(15):12509. doi: 10.3390/ijms241512509.
7
Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases.基于双氯芬酸的新型疗法的发展与挑战:针对癌症和复杂疾病
Cancers (Basel). 2022 Sep 9;14(18):4385. doi: 10.3390/cancers14184385.
8
Epigenetic Silencing of 15-Hydroxyprostaglandin Dehydrogenase by Histone Methyltransferase EHMT2/G9a in Cholangiocarcinoma.在胆管癌中,组蛋白甲基转移酶 EHMT2/G9a 对 15-羟前列腺素脱氢酶进行表观遗传沉默。
Mol Cancer Res. 2022 Mar 1;20(3):350-360. doi: 10.1158/1541-7786.MCR-21-0536.
9
Perioperative NSAIDs and Long-Term Outcomes After cancer Surgery: a Systematic Review and Meta-analysis.围手术期非甾体抗炎药与癌症手术后长期结局:系统评价和荟萃分析。
Curr Oncol Rep. 2021 Nov 8;23(12):146. doi: 10.1007/s11912-021-01133-8.
10
Role of autophagy in cholangiocarcinoma: An autophagy-based treatment strategy.自噬在胆管癌中的作用:一种基于自噬的治疗策略。
World J Gastrointest Oncol. 2021 Oct 15;13(10):1229-1243. doi: 10.4251/wjgo.v13.i10.1229.